AP1AR Activators
AP1AR Activators encompass a range of chemical compounds that work through adrenergic signaling and cAMP-mediated pathways to amplify the activity of AP1AR. Key activators such as Isoproterenol, Norepinephrine, and Epinephrine bind to adrenergic receptors and initiate a signaling cascade by stimulating adenylyl cyclase, thereby increasing intracellular cAMP levels andactivating protein kinase A (PKA). PKA, in turn, phosphorylates and enhances the functional sensitivity and activity of AP1AR, providing a mechanism for the upregulated response to cellular signals. Similarly, selective beta2-adrenergic receptor agonists like Salbutamol, Albuterol, and Terbutaline target the same pathway with specificity towards tissues expressing beta2-adrenergic receptors, leading to localized enhancement of AP1AR activity. Dobutamine, although structurally similar to the aforementioned catecholamines, preferentially stimulates beta1-adrenergic receptors, particularly in cardiac tissue, thereby indirectly increasing AP1AR activity through the beta1-adrenergic receptor subset.
Complementary to receptor agonists are compounds like Forskolin, which bypass receptor-mediated stimulation and directly activate adenylyl cyclase, promoting a sustained increase in cAMP and subsequent PKA-mediated enhancement of AP1AR. Rolipram and IBMX further augment AP1AR activity by inhibiting phosphodiesterase 4 and non-selective phosphodiesterases, respectively, leading to an accumulation of cAMP and a continuous activation of downstream PKA signaling. Caffeine, through its antagonistic effects on phosphodiesterases, also contributes to this increase in cAMP levels, albeit via competitive inhibition, thereby extending the PKA signaling duration and enhancing AP1AR activity. Lastly, Olodaterol, a long-acting beta2-adrenergic agonist, ensures prolonged activation of adenylyl cyclase, resulting in sustained cAMP and PKA signaling, thereby facilitating the extended enhancement of AP1AR in target tissues such as the respiratory system. Collectively, these AP1AR Activators operate through finely tuned cAMP-dependent pathways, each contributing to the amplified functional activity of AP1AR within various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine and beta-adrenergic agonist that directly stimulates adenylyl cyclase via beta-adrenergic receptors, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP levels activate protein kinase A (PKA), which can phosphorylate and enhance the activity of AP1AR by increasing its sensitivity to cellular signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene that directly activates adenylyl cyclase, leading to a rise in cAMP levels. This activation of adenylyl cyclase bypasses the receptor-mediated activation mechanism, thus potentiating the PKA pathway and enhancing the activity of AP1AR through cAMP-dependent mechanisms. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine is a neurotransmitter and hormone that acts as an agonist at alpha and beta-adrenergic receptors. Its interaction with beta-adrenergic receptors stimulates adenylyl cyclase, increasing cAMP levels and subsequently activating PKA, which can then enhance the functional activity of AP1AR. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, also known as adrenaline, is an endogenous catecholamine that binds to beta-adrenergic receptors, activating adenylyl cyclase, and increasing cAMP levels. This cascade of events leads to the activation of PKA, which can phosphorylate and enhance AP1AR activity. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a selective beta2-adrenergic receptor agonist that stimulates adenylyl cyclase to increase cAMP levels, activating PKA. The subsequent phosphorylation events can enhance the activity of AP1AR in tissues expressing beta2-adrenergic receptors. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine is a synthetic catecholamine that acts primarily on beta1-adrenergic receptors, leading to adenylyl cyclase activation and an increase in cAMP levels. This effect activates PKA, which may enhance AP1AR activity, particularly in cardiac tissue where beta1-adrenergic receptors are prevalent. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which leads to an accumulation of cAMP within the cell due to reduced degradation. This increased level of cAMP can activate PKA, thereby enhancing the activity of AP1AR through secondary messenger-mediated pathways. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a competitive inhibitor of phosphodiesterases, which leads to increased cAMP levels by preventing the breakdown of this secondary messenger. The resulting activation of PKA can enhance the activity of AP1AR indirectly. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, or 3-isobutyl-1-methylxanthine, is a nonspecific inhibitor of phosphodiesterases, causing an increase in cAMP levels and activation of PKA, which subsequently can enhance AP1AR activity through cAMP-dependent signaling pathways. | ||||||